The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge
- PMID: 21035175
- PMCID: PMC7126001
- DOI: 10.1016/j.jaci.2010.08.025
The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge
Abstract
Background: Delayed-onset urticarial or maculopapular rashes are frequently observed in children treated with β-lactams. Many are labeled "allergic" without reliable testing.
Objective: Determine the etiology of these rashes by exploring both infectious and allergic causes.
Methods: Children presenting to the emergency department with delayed-onset urticarial or maculopapular rashes were enrolled. Acute and convalescent sera were obtained for viral screening along with a throat swab. Subjects underwent intradermal and patch skin testing for β-lactams 2 months after presentation. Anti-β-lactam blood allergy tests were also obtained. All subjects underwent an oral challenge test (OCT) with the culprit antibiotic.
Results: Eighty-eight children were enrolled between 2006 and 2008. There were 11 (12.5%) positive intradermal and no positive patch tests. There were 2 (2.3%) positive blood allergy tests. There were 6 (6.8%) subjects with a positive OCT, 2 were intradermal-negative, and 4 were intradermal-positive. No OCT reactions were more severe than the index event. Most subjects had at least 1 positive viral study, 54 (65.9%) in the OCT negative group.
Conclusion: In this situation, β-lactam allergy is clearly overdiagnosed because the skin rash is only rarely reproducible (6.8%) by a subsequent challenge. Viral infections may be an important factor in many of these rashes. OCTs were positive in a minority of intradermal skin test-positive subjects. Patch testing and blood allergy testing provided no useful information. OCTs should be considered in all children who develop a delayed-onset urticarial or maculopapular rash during treatment with a β-lactam.
Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Comment in
-
Retesting in children with β-lactam allergy.J Allergy Clin Immunol. 2011 Aug;128(2):429; author reply 429-30. doi: 10.1016/j.jaci.2011.04.041. Epub 2011 May 18. J Allergy Clin Immunol. 2011. PMID: 21596422 No abstract available.
-
A suspicion of antibiotic allergy in children is often incorrect.J Allergy Clin Immunol. 2012 Feb;129(2):583; author reply 583-4. doi: 10.1016/j.jaci.2011.11.027. Epub 2011 Dec 22. J Allergy Clin Immunol. 2012. PMID: 22196770 Free PMC article. No abstract available.
References
-
- Cars O., Molstad S., Melander A. Variation in antibiotic use in the European Union. Lancet. 2001;357:1851–1853. - PubMed
-
- Adkinson N.F., Jr. Risk factors for drug allergy. J Allergy Clin Immunol. 1984;74:567–572. - PubMed
-
- Romano A. Recognising antibacterial hypersensitivity in children. Paediatr Drugs. 2000;2:101–112. - PubMed
-
- Bierman C.W., Pierson W.E., Zeitz S.J., Hoffman L.S., VanArsdel P.P., Jr. Reactions associated with ampicillin therapy. JAMA. 1972;220:1098–1100. - PubMed
-
- Ponvert C., Weilenmann C., Wassenberg J., Walecki P., Bourgeois M.L., de Blic J. Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge tests. Allergy. 2007;62:42–46. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
